Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Transactions
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Appointed director
Sonoma Pharmaceuticals, Inc. (SNOA) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/21/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
04/13/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/12/2022 3 White Chad Norman (Interim CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
09/11/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
04/23/2020 3 Edwards Robert Grant (CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
10/17/2019 3 Trombly Amy Moss (Interim CEO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
10/15/2019 3 Dal Poggetto John (CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
12/21/2018 3 Sandford Frederick J (CEO and Interim CFO) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
09/21/2018 3 Weigerstorfer Philippe (Director) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
01/10/2017 3 Umscheid Marc (Chief Strategy/Mkt Officer) has filed a Form 3 on Sonoma Pharmaceuticals, Inc.
03/22/2013 3 MCLAUGHLIN JOHN (Director) has filed a Form 3 on Oculus Innovative Sciences, Inc.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy